DEVOTE 3: temporal relationships between severe hypoglycaemia, cardiovascular outcomes and mortality
Pieber TR, Marso SP, McGuire DK, et al.
Diabetologia 2018;61(1):58-65
Leggi
Breaking news
Maternal obesity as a risk factor for early childhood type 1 diabetes: a nationwide, prospective, population-based case–control study
Lindell N, Carlsson A, Josefsson A, et al.
Diabetologia 2018; 61(1):130-7
Leggi
The Potential Impact of Food Taxes and Subsidies on Cardiovascular Disease and Diabetes Burden and Disparities in the United States
Peñalvo JL, Cudhea F, Micha R
BMC Medicine. Published on: 27 November 2017
Leggi
Repaglinide Versus Insulin For Newly Diagnosed Diabetes In Patients With Cystic Fibrosis: A Multicentre, Open-Label, Randomised Trial
Ballmann M, Hubert D, Assael BM, et al.
The Lancet Diabetes & Endocrinology. Pub. online 30 November 2017.
Leggi
Cystic-Fibrosis-Related Diabetes: Time for Oral Drugs?
Moran A
The Lancet Diabetes & Endocrinology. Pub. online 30 November 2017.
Leggi
Cardiovascular Mortality and Oral Antidiabetic Drugs: Protocol for a Systematic Review and Network Meta-Analysis
Goyat R, Douglas Thornton J, Tan X, et al.
BMJ Open. 2017;7:e017644
Leggi
Impact of Multimorbidity on Healthcare Professional Task Shifting Potential in Patients with Type 2 Diabetes in Primary Care: A French Cross-Sectional Study
Supper I, Bourgueil Y, Ecochard R et al.
BMJ Open. 2017;7:e016545
Leggi
Remission of Type 2 Diabetes: Mission Not Impossible
Uusitupa M
The Lancet. Pub. online 5 December 2017.
Leggi
Primary Care-Led Weight Management for Remission of Type 2 Diabetes (DiRECT): An Open-Label, Cluster-Randomised Trial
Lean MEJ, Leslie WS, Barnes AC, et al.
The Lancet. Pub. online 5 December 2017.
Leggi
GP Based Weight Loss Programme Can Reverse Type 2 Diabetes
Kmietowicz Z
BMJ. 2017;359:j5641
Leggi